To The Moon

Sign Up

Quikening

    • QuikeningQuikening
      ·10-25
      $Circle Internet Corp.(CRCL)$ 
      192Comment
      Report
    • QuikeningQuikening
      ·10-25
      $NBIS 20260116 90.0 PUT$ 
      136Comment
      Report
    • QuikeningQuikening
      ·08-12
      $203
      558Comment
      Report
    • QuikeningQuikening
      ·06-23
      $Coupang, Inc.(CPNG)$  No. Not good enough a stock. it will take many months to hit potential. Run while I can make a profit
      2.56K3
      Report
    • QuikeningQuikening
      ·02-26
      Is this some fake news. NVDA earnings hasn't been announced yet. 

      Stock Track | GraniteShares 2x Long NVDA Daily ETF Plummets 5.03% Following NVIDIA's Earnings Release

      The GraniteShares 2x Long NVDA Daily ETF tumbled 5.03% on Tuesday, underperforming the broader market. This plummet came in the wake of NVIDIA's highly anticipated earnings report, which was released after the market close on Wednesday, February 22nd.NVIDIA, the underlying stock that NVDL tracks with 2x leverage, had a rocky start to the year due to concerns over competition from Chinese AI firm DeepSeek. However, individual investors remained bullish on the stock, pouring billions into NVIDIA
      Stock Track | GraniteShares 2x Long NVDA Daily ETF Plummets 5.03% Following NVIDIA's Earnings Release
      1.89KComment
      Report
    • QuikeningQuikening
      ·2021-09-23
      $Novavax(NVAX)$GAITHERSBURG, Md., Sept. 23, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, with its partner, Serum Institute of India Pvt. Ltd. (SII), today announced a regulatory submission to the World Health Organization (WHO) for emergency use listing (EUL) of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine candidate with Matrix-MTM adjuvant. The submission to WHO is based on the companies' previous regulatory submission to the Drugs Controller General of India (DCGI)."Today's submission of our protein-based COVID-19 vaccine to WHO for emergency use listing is a significant step on the path to accelera
      2.15KComment
      Report
    • QuikeningQuikening
      ·2021-09-15
      $Novavax(NVAX)$https://www.fool.com/investing/2021/09/15/is-novavax-a-buy/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article&yptr=yahooNice!
      2.07KComment
      Report
    • QuikeningQuikening
      ·2021-09-09
      $Novavax(NVAX)$Do y’all think it will fall a little? To what price? So that I can accumulate!!!!
      1.79KComment
      Report
    • QuikeningQuikening
      ·2021-08-25
      $Novavax(NVAX)$In the U.K., novavax, which is not even approved yet, is going to be in a booster study https://www.gov.uk/government/news/new-study-to-test-third-covid-19-vaccine-for-people-with-weakened-immune-systems
      1.82KComment
      Report
    • QuikeningQuikening
      ·2021-08-16
      Accumulate and average down?
      @Jamesnyh：
      $BioNTech SE(BNTX)$Who can help me???
      $BioNTech SE(BNTX)$Who can help me???
      1.72KComment
      Report
       
       
       
       

      Most Discussed